Amylin Strikes First With Obesity Drug Deal: Biobuzz

Japanese drugmaker Takeda licenses worldwide rights to Amylin weight-loss pipeline.

Topics:  takeda   amylin   drug   
BING NEWS:
  • Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
    A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop multi-payload antibody-drug conjugates. | A new weight-loss biotech launched ...
    01/10/2025 - 12:00 am | View Link
  • Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
    Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on Wednesday, citing the Centers for Medicare & Medicaid Services.
    01/9/2025 - 1:25 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News